Nutrient composition and safety evaluation of simulated isobutanol distillers dried grains with solubles and associated fermentation metabolites when fed to male Ross 708 broiler chickens (Gallus domesticus)

PLoS One. 2019 Jul 8;14(7):e0219016. doi: 10.1371/journal.pone.0219016. eCollection 2019.

Abstract

Saccharomyces cerevisiae genetically engineered to enhance butanol production will be used in a manufacturing process similar to that of fuel ethanol production, including co-production of distillers products for animal feed. A poultry feeding trial was conducted with simulated isobutanol-derived dried distillers grains with solubles (bDDGS), comprising non-fermentable corn solids and heat-inactivated Butamax modified yeast (BMY), to determine potential health effects. Simulated dried distillers grains were produced in 2 variants: bDDGS containing 10% (B10) or 50% (B50) BMY. The BMY concentrations were selected based on a conservative estimate from ethanol-derived distillers grains (eDDGS) approximating 2.5 and 12-fold margins of exposure. The B10 and B50 DDGS were evaluated in a 42-day feeding trial using male Ross 708 broiler chickens fed diets containing eDDGS, B50 DDGS, or B10 DDGS without or with isobutanol, 2,3-butanediol, and isobutyric acid metabolites each at target concentrations of 2 (B10-2), 5 (B10-5), or 10 (B10-10) times the anticipated specification limit in the commercial product. Diets were fed (n = 50 broilers/treatment) in 3 phases: starter phase with 8% DDGS and grower and finisher phases each with 15% DDGS. No statistically significant differences or diet-related effects on mortality, clinical pathology, or organ weights, and no microscopic observations associated with consumption of diets containing B10, B50, or B10 supplemented with metabolites at any targeted exposure level were observed. A lower (P < 0.05) mean absolute bursa of Fabricius weight in the B10-10 group compared to the B10 group was considered to be within the range of biological variability. A non-significant trend toward lower weight, gains, and feed intake, and higher feed:gain ratio was observed in the B10-10 group, and was considered a non-adverse palatability effect of consuming high concentrations of metabolites. These results demonstrate that consumption of phase diets containing simulated DDGS from a novel isobutanol production process was well-tolerated.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animal Feed / adverse effects
  • Animal Feed / analysis*
  • Animal Nutritional Physiological Phenomena
  • Animals
  • Biofuels
  • Butanols / administration & dosage*
  • Butanols / adverse effects
  • Butanols / metabolism
  • Chickens / growth & development
  • Distillation / methods
  • Edible Grain / chemistry
  • Fermentation
  • Genetic Engineering
  • Male
  • Saccharomyces cerevisiae / genetics
  • Saccharomyces cerevisiae / metabolism
  • Safety

Substances

  • Biofuels
  • Butanols
  • isobutyl alcohol

Grants and funding

All funding for the work described herein was provided by Butamax Advanced Biofuels, LLC, the producer of Butamax Modified Yeast. K.S. Reidinger is an employee of Butamax Advanced Biofuels, LLC, the funders of this work. K.S. Reidinger had no role in the study design, or data collection and analysis. However, Butamax Advanced Biofuels, LLC did support the decision to publish, and K.S. Reidinger contributed to the preparation and review of the manuscript and supporting information.